Jing Marantz
Chief Tech/Sci/R&D Officer at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 3 M $ as of 30/12/2024
Profile
Dr. Jing L. Marantz is a Senior Vice President-Medical Affairs at Acceleron Pharma, Inc. She is on the Board of Directors at Krystal Biotech, Inc. Dr. Marantz was previously employed as a Head-Medical Affairs & Senior Vice President by Alnylam Pharmaceuticals, Inc., a Vice President-Medical Affairs by ARIAD Pharmaceuticals, Inc., and a Vice President-Global Medical Affairs by Alexion Pharmaceuticals, Inc. She received her MBA from Haas School of Business, a doctorate degree from Tongji Medical College of Huazhong University of Sci & Tech and a doctorate degree from Medical University of South Carolina.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
15/01/2025 | 67,200 ( 0.07% ) | 3 M $ | 30/12/2024 | |
13/06/2024 | 3,131 ( 0.01% ) | 53 133 $ | 30/12/2024 |
Latest news about Jing Marantz
Jing Marantz active positions
Companies | Position | Start |
---|---|---|
ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 06/12/2021 |
SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 08/11/2022 |
Arcturus Therapeutics Ltd.
![]() Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Arcturus Therapeutics, Inc.
![]() Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Former positions of Jing Marantz
Companies | Position | End |
---|---|---|
KRYSTAL BIOTECH, INC. | Director/Board Member | 17/01/2022 |
ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 31/10/2021 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/08/2020 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/05/2018 |
ARIAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Jing Marantz
Tongji Medical College of Huazhong University of Sci & Tech | Doctorate Degree |
Medical University of South Carolina | Doctorate Degree |
University of California, Berkeley | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
Private companies | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
![]() Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Arcturus Therapeutics Ltd.
![]() Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics, Inc.
![]() Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Jing Marantz